Vault-13

TRINITY BIOTECH PLC

SPON ADR NEW · CUSIP 896438306

0 institutional holders -27 vs Q4 2023
—reported value*
0 new 0 added 0 reduced 26 sold out net sold ≈ $2.6m (-6.0m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q1 2024

Institutional holders

Managers reporting a position, each quarter

0102030Q3 22: 22Q4 22: 21Q1 23: 21Q2 23: 21Q3 23: 21Q4 23: 27Q1 24: 00Q3 22Q1 23Q3 23Q1 24
Numbers
QuarterHolders
Q3 202222
Q4 202221
Q1 202321
Q2 202321
Q3 202321
Q4 202327
Q1 20240

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
40040Q4 22: 3 bought or addedQ4 22: 10 cut or sold outQ4 22Q1 23: 4 bought or addedQ1 23: 9 cut or sold outQ1 23Q2 23: 4 bought or addedQ2 23: 8 cut or sold outQ2 23Q3 23: 2 bought or addedQ3 23: 5 cut or sold outQ3 23Q4 23: 7 bought or addedQ4 23: 7 cut or sold outQ4 23Q1 24: 0 bought or addedQ1 24: 26 cut or sold outQ1 24
Numbers
QuarterBought or addedCut or sold out
Q4 2022310
Q1 202349
Q2 202348
Q3 202325
Q4 202377
Q1 2024026

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$5k$10k$15k$20kQ2 23 calls: $4.2kQ2 23 puts: $17.0kQ2 23P/C 4.09Q3 23 calls: $0Q3 23 puts: $12.7kQ3 23P/C —Q4 23 calls: $429Q4 23 puts: $0Q4 23P/C 0.00Q1 24 calls: $0Q1 24 puts: $0Q1 24P/C —
Numbers
QuarterCallsPutsP/C
Q2 2023$4.2k$17.0k4.09
Q3 2023$0$12.7k—
Q4 2023$429$00.00
Q1 2024$0$0—

Biggest buyers

None

Biggest sellers

HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC Sold out -1,625,900-1.6m
STONEHILL CAPITAL MANAGEMENT LLC Sold out -1,512,975-1.5m
RENAISSANCE TECHNOLOGIES LLC Sold out -1,353,898-1.4m
ACADIAN ASSET MANAGEMENT LLC Sold out -684,882-684.9k
Whitefort Capital Management, LP Sold out -409,517-409.5k
Cambridge Investment Research Advisors, Inc. Sold out -111,400-111.4k
BECKER CAPITAL MANAGEMENT INC Sold out -90,000-90.0k
CITADEL ADVISORS LLC Sold out -32,513-32.5k
MORGAN STANLEY Sold out -29,104-29.1k
Aristides Capital LLC Sold out -28,057-28.1k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
MiCo IVD Holdings, LLC 13D · may seek influence filed 2024-12-19
Stated purposeItem 4 of Schedule 13D is hereby amended by deleting the final paragraph and replacing with the following new paragraphs: On December 17, 2024, Mainstream Holdings, Ltd. (the "Mainstream Holdings"), the beneficial owner of 100% of the interests of MiCo IVD, entered into a Share Purchase Agreement with DAYLI Holdings (the "2024 Share Purchase Agreement"), pursuant to which Mainstream Holdings agreed to sell to DAYLI Holdings all of its equity interests in MiCo IVD for a total of 15,000,000,000 South Korean won (the "2024 MiCo IVD Purchase"). The 2024 MiCo IVD Purchase is expected to close on December 20, 2024, following which time DAYLI Holdings will become the sole shareholder of MiCo IVD. In connection with the 2024 MiCo IVD Purchase, on December 17, 2024, Mainstream Holdings and MiCo Par… Full filing
 18.0% 69.5m 2024-12-19
Novus Diagnostics Ltd. 13G · passive investor new · filed 2026-03-06 6.0% new 1.1m 2026-03-06

Holders, Q1 2024

#ManagerLocationShares Value% of their portfolioChangeShares change